Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

TBD, Turkey Clinical Trials

A listing of TBD, Turkey clinical trials actively recruiting patients volunteers.


Found (334) clinical trials

Prostate Cancer Upgrading Reference Set

The primary endpoint of this study is the presence of tumor upgrading at the time of radical prostatectomy. Upgrading is defined as: Gleason 3+4 or higher grade A secondary study endpoint is presence of prostate cancer beyond the prostate (pathologic T3 disease) at radical prostatectomy. (This finding may be considered ...

Phase N/A

Clinical Evaluation of Patients With X-linked Retinitis Pigmentosa (XLRP)

Males with a clinical diagnosis of X-linked retinitis pigmentosa (XLRP) caused by RPGR-ORF15 mutations will be asked to provide informed consent and will have a single blood or saliva sample obtained for DNA sequence analysis of genes known to cause XLRP, including the RPGR-ORF15 gene. All participants will be informed ...

Phase N/A

Focused Stereotactic Radiation Treatment of Prostatic Adenocarcinoma

Focused stereotactic radiation treatment of localized prostatic adenocarcinoma. in order to quantify the delay between the focused treatment and the salvage procedure. Second objectives : objectives: prostate-specific antigen (PSA) response, MRI response, toxicity (CTCAEv4), quality of life (International Prostate Symptom Score (IPSS) and The International Index of Erectile Function (IIEF5) ...

Phase N/A

Distribution of Smooth Muscle In Dartos In The Non Conspicuous Penis

After informed consent, patients will be labeled with a research record number other than the identity document or the number of the attention. The urologist who perform the correction of the megaprepuce, will take a segment of the dartos and send it for histopathological analysis: staining with hematoxylin-eosin, smooth muscle ...

Phase N/A

Prostate Active Surveillance Study

This is a multi-center, prospective active surveillance study with selective intervention in patients with previously untreated, clinically localized prostate cancer at diagnosis. Candidates are assessed based on an extended core biopsy, serum PSA (including PSA kinetics, if available), digital rectal examination (DRE), and assessment of cancer grade and extent. Active ...

Phase N/A

Identification of Predictors for Early Cognitive Decline in Men

The research program explores how aging influences brain function in test-persons from a Danish birth cohort of men born in 1953 in the Metropolitan area of Copenhagen. Test-persons are divided among three groups based on performance in cognitive tests at late midlife compared to young adulthood; 1) Positive expected performance, ...

Phase N/A

Active Surveillance for Cancer of the Prostate (ASCaP)

This protocol is not designed as a formal clinical trial, but rather an observational protocol; no treatments and no randomization are included. Longitudinally, specimens and clinical data will be collected to provide information on the following: Imaging studies of the prostate Rates of curative intervention Measures of tumor recurrence/progression Disease ...

Phase N/A

Decipher the Biology of Lethal Prostate Cancer Using Urine Metabolomics Profiling to Search for Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer Patients

Prostate cancer (PC) afflicts millions of men worldwide. In Taiwan, around 5,000 men are diagnosed as PC while 1,200 men die of the disease each year. Although there is a significant advance in the definitive treatments of PC, the failure rate is still up to 40%. Androgen deprivation therapy (ADT) ...

Phase N/A

Seoul National University Prospectively Enrolled Registry for Prostate Cancer With Active Surveillance

Prostate cancer (PCa) remains one of the most commonly diagnosed malignancies in men worldwide. Early diagnosis and definitive therapy seem to improve oncological outcomes in men with high-risk disease, but significant concerns exist in terms of the overdiagnosis and overtreatment of patients with lower-risk tumors. In this context, active surveillance ...

Phase N/A

Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI)

Primary Objective(s) Confirm performance of the ExoDx Prostate (IntelliScore) (EPI) utilizing a designated collection vessel for men presenting for their initial prostate biopsy with an elevated Prostate-specific antigen (2-10 ng/mL). Evaluate impact of the confirmed ExoDx Prostate (IntelliScore) on the decision to perform an initial prostate biopsy for men presenting ...

Phase N/A